What is the prognosis of nasal-type NK/T-cell lymphoma?

Updated: Aug 15, 2018
  • Author: Lauren C Pinter-Brown, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Nasal-type NK/T-cell lymphoma manifesting in the skin is highly aggressive, and patients have a median survival period of less than 12 months. [54, 55] The most important factor in predicting a poor outcome is the initial presence of extracutaneous involvement. Patients first seen with only cutaneous involvement had a median survival of 27 months, compared with months for patients presenting with cutaneous and extracutaneous disease. [55]

CD30+, CD56+ patients seem to have a better prognosis, possibly being examples of cutaneous anaplastic large cell lymphoma with coexpression of CD56. [56]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!